menu search

Why tesla's solar business has not yet taken off as elon musk promised

It's been five years since Tesla acquired SolarCity. CNBC interviewed experts and Tesla solar customers to see how the company is delivering on its pr...

October 6, 2021, 8:30 am

Hyzon motors: bear raid looks like it missed its target

HYZN stock still is down 30% from where it traded before Blue Orca Capital released a short report last week with allegations including fake orders, f...

October 6, 2021, 8:30 am

Hyzon motors: bear raid looks like it missed its target

HYZN stock still is down 30% from where it traded before Blue Orca Capital released a short report last week with allegations including fake orders, f...

October 6, 2021, 8:30 am

Hyzon motors: bear raid looks like it missed its target

HYZN stock still is down 30% from where it traded before Blue Orca Capital released a short report last week with allegations including fake orders, f...

October 6, 2021, 8:30 am

Why gilead sciences investors shouldn't give up on remdesivir just yet

A new study shows it is highly effective in preventing deaths if taken early....

October 6, 2021, 6:18 am

Why gilead sciences investors shouldn't give up on remdesivir just yet

A new study shows it is highly effective in preventing deaths if taken early....

October 6, 2021, 6:18 am

Why gilead sciences investors shouldn't give up on remdesivir just yet

A new study shows it is highly effective in preventing deaths if taken early....

October 6, 2021, 6:18 am

Ubs clients raise $650 million for biggest yet biotech impact fund

UBS's wealthy clients have raised $650 million for the biggest biotechnology impact fund ever, the Swiss bank said on Wednesday....

October 6, 2021, 2:04 am

Ubs clients raise $650 million for biggest yet biotech impact fund

UBS's wealthy clients have raised $650 million for the biggest biotechnology impact fund ever, the Swiss bank said on Wednesday....

October 6, 2021, 2:04 am

Ubs clients raise $650 million for biggest yet biotech impact fund

UBS's wealthy clients have raised $650 million for the biggest biotechnology impact fund ever, the Swiss bank said on Wednesday....

October 6, 2021, 2:04 am

Senators demand facebook ceo mark zuckerberg answer questions after whistleblower's revelations at hearing

At Tuesday's hearing with Facebook whistleblower Frances Haugen, senators asked why CEO Mark Zuckerberg has ye...

October 5, 2021, 3:27 pm

Senators demand facebook ceo mark zuckerberg answer questions after whistleblower's revelations at hearing

At Tuesday's hearing with Facebook whistleblower Frances Haugen, senators asked why CEO Mark Zuckerberg has ye...

October 5, 2021, 3:27 pm

Senators demand facebook ceo mark zuckerberg answer questions after whistleblower's revelations at hearing

At Tuesday's hearing with Facebook whistleblower Frances Haugen, senators asked why CEO Mark Zuckerberg has ye...

October 5, 2021, 3:27 pm

Senators demand facebook ceo mark zuckerberg answer questions after whistleblower's revelations at hearing

At Tuesday's hearing with Facebook whistleblower Frances Haugen, senators asked why CEO Mark Zuckerberg has ye...

October 5, 2021, 3:27 pm

Senators demand facebook ceo mark zuckerberg answer questions after whistleblower's revelations at hearing

At Tuesday's hearing with Facebook whistleblower Frances Haugen, senators asked why CEO Mark Zuckerberg has ye...

October 5, 2021, 3:27 pm

Merck's good news doesn't end the bullish story for novavax

Investors are pointing fingers at Merck, but a tricky start to October could yet turn into a treat for ...

October 5, 2021, 1:16 pm

Merck's good news doesn't end the bullish story for novavax

Investors are pointing fingers at Merck, but a tricky start to October could yet turn into a treat for ...

October 5, 2021, 1:16 pm

Merck's good news doesn't end the bullish story for novavax

Investors are pointing fingers at Merck, but a tricky start to October could yet turn into a treat for ...

October 5, 2021, 1:16 pm

Merck's good news doesn't end the bullish story for novavax

Investors are pointing fingers at Merck, but a tricky start to October could yet turn into a treat for ...

October 5, 2021, 1:16 pm

Merck's good news doesn't end the bullish story for novavax

Investors are pointing fingers at Merck, but a tricky start to October could yet turn into a treat for ...

October 5, 2021, 1:16 pm


Search within

Pages Search Results: